MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ccrj.2026.100223

Медицинская библиотека · Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine · 2026

Low-intensity versus medium-intensity continuous renal replacement therapy for critically ill patients (LIMIT) trial: Protocol summary and statistical analysis plan of a randomised clinical trial.

Fujii Tomoko, Amemiya Yu, Endo Akira, Iguchi Naoya, Imahase Hisashi, Kawazoe Yu, Miyamoto Kyohei, Okuzawa Hiraaki, Tanaka Aiko, Yamamoto Ryo, Chida Makoto, Furukawa Megumi, Tanaka Shiro, LIMIT trial investigators

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Severe acute kidney injury in critically ill patients may require continuous renal replacement therapy (CRRT), yet mortality remains high. A standard CRRT intensity is 20-25 mL/kg/hr, because higher doses have not improved outcomes. Excessive treatment may cause harm by removing antibiotics and other essential substances and potentially impairing renal recovery. Observational data suggest that lower-intensity CRRT may be effective, warranting a clinical trial to compare low-versus standard-intensity therapy.

OBJECTIVE

The objective of this study was to describe the prespecified protocol and the statistical analysis plan of the low-intensity versus medium-intensity continuous renal replacement therapy for critically Ill patients (LIMIT) trial.

DESIGN SETTING PARTICIPANTS AND INTERVENTIONS: The LIMIT trial is an investigator-initiated, multicentre, open-label, randomised clinical trial, with a target sample size of 400 participants. The trial compares low-intensity CRRT (12 mL/kg/hr) and medium-intensity CRRT (25 mL/kg/hr) in adult patients with acute kidney injury requiring CRRT in the participating intensive care units.

MAIN OUTCOME MEASURES: The primary outcome is a hierarchical composite of survival and time to successful liberation from RRT through day 28 from randomisation, analysed using a win-ratio. Secondary outcomes include intensive care unit mortality, hospital mortality, dialysis dependence at hospital discharge among survivors, vasopressor-free days at day 28, and ventilator-free days at day 28.

CONCLUSION

The LIMIT trial will evaluate the effect of low-intensity CRRT on mortality and time to successful liberation from RRT compared with medium-intensity CRRT in adults with acute kidney injury. Its findings may also inform future research on broader patient-centred and societal implications of CRRT intensity.

Для цитирования: Fujii Tomoko, Amemiya Yu, Endo Akira, Iguchi Naoya, Imahase Hisashi, Kawazoe Yu, Miyamoto Kyohei, Okuzawa Hiraaki, Tanaka Aiko, Yamamoto Ryo, Chida Makoto, Furukawa Megumi, Tanaka Shiro, LIMIT trial investigators. Low-intensity versus medium-intensity continuous renal replacement therapy for critically ill patients (LIMIT) trial: Protocol summary and statistical analysis plan of a randomised clinical trial.. Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine. 2026. DOI: 10.1016/j.ccrj.2026.100223.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.